Stodolak-Zych Ewa, Rapacz-Kmita Alicja, Gajek Marcin, Różycka Agnieszka, Dudek Magdalena, Kluska Stanisława
Faculty of Materials Science and Ceramics, AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland.
Faculty of Energy and Fuels, AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland.
J Funct Biomater. 2023 Mar 21;14(3):167. doi: 10.3390/jfb14030167.
The aim of the work was to examine the possibility of using modified halloysite nanotubes as a gentamicin carrier and to determine the usefulness of the modification in terms of the effect on the amount of the drug attached, its release time, but also on the biocidal properties of the carriers. In order to fully examine the halloysite in terms of the possibility of gentamicin incorporating, a number of modifications of the native halloysite were carried out prior to gentamicin intercalation with the use of sodium alkali, sulfuric and phosphoric acids, curcumin and the process of delamination of nanotubes (expanded halloysite) with ammonium persulfate in sulfuric acid. Gentamicin was added to unmodified and modified halloysite in an amount corresponding to the cation exchange capacity of pure halloysite from the Polish Dunino deposit, which was the reference sample for all modified carriers. The obtained materials were tested to determine the effect of surface modification and their interaction with the introduced antibiotic on the biological activity of the carrier, kinetics of drug release, as well as on the antibacterial activity against Gram-negative bacteria (reference strain). For all materials, structural changes were examined using infrared spectroscopy (FTIR) and X-ray diffraction (XRD); thermal differential scanning calorimetry with thermogravimetric analysis (DSC/TG) was performed as well. The samples were also observed for morphological changes after modification and drug activation by transmission electron microscopy (TEM). The conducted tests clearly show that all samples of halloysite intercalated with gentamicin showed high antibacterial activity, with the highest antibacterial activity for the sample modified with sodium hydroxide and intercalated with the drug. It was found that the type of halloysite surface modification has a significant effect on the amount of gentamicin intercalated and then released into the surrounding environment but does not significantly affect its ability to further influence drug release over time. The highest amount of drug released among all intercalated samples was recorded for halloysite modified with ammonium persulfate (real loading efficiency above 11%), for which high antibacterial activity was found after surface modification, before drug intercalation. It is also worth noting that intrinsic antibacterial activity was found for non-drug-intercalated materials after surface functionalization with phosphoric acid (V) and ammonium persulfate in the presence of sulfuric acid (V).
这项工作的目的是研究使用改性埃洛石纳米管作为庆大霉素载体的可能性,并从对附着药物量、其释放时间的影响以及对载体杀菌性能的影响方面确定改性的有效性。为了全面研究埃洛石在庆大霉素掺入可能性方面的情况,在使用氢氧化钠、硫酸和磷酸、姜黄素以及用硫酸中的过硫酸铵对纳米管进行分层处理(膨胀埃洛石)的过程中,对天然埃洛石进行了多种改性,然后将庆大霉素插入其中。以波兰杜尼诺矿床的纯埃洛石的阳离子交换容量为对应量,将庆大霉素添加到未改性和改性的埃洛石中,该纯埃洛石是所有改性载体的参考样品。对获得的材料进行测试,以确定表面改性及其与引入的抗生素的相互作用对载体生物活性、药物释放动力学以及对革兰氏阴性菌(参考菌株)的抗菌活性的影响。对于所有材料,使用红外光谱(FTIR)和X射线衍射(XRD)检查结构变化;还进行了带有热重分析的热差示扫描量热法(DSC/TG)。通过透射电子显微镜(TEM)观察样品在改性和药物活化后的形态变化。所进行的测试清楚地表明,所有插入庆大霉素的埃洛石样品都表现出高抗菌活性,其中用氢氧化钠改性并插入药物的样品抗菌活性最高。发现埃洛石表面改性的类型对插入然后释放到周围环境中的庆大霉素量有显著影响,但对其随时间进一步影响药物释放的能力没有显著影响。在所有插入样品中,过硫酸铵改性的埃洛石释放的药物量最高(实际负载效率超过11%),在药物插入之前,该样品在表面改性后具有高抗菌活性。还值得注意的是,在用磷酸(V)和过硫酸铵在硫酸(V)存在下对非药物插入材料进行表面功能化后,发现了固有抗菌活性。